BPG致力于知识发现和传播
Articles Published Processes
2021/9/8 11:53:42 | Browse: 322 | 下载: 500
Publication Name |
世界华人消化杂志 |
手稿编号 |
38313 |
手稿来源省、自治区或特别行政区 |
广西壮族自治区 |
|
Received |
|
2021-04-22 06:00 |
|
Peer-Review Started |
|
2021-04-23 01:01 |
|
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-05-13 03:29 |
|
修回稿 |
|
2021-05-17 05:27 |
|
Second Decision |
|
2021-06-25 07:38 |
|
期刊总编辑接受 |
|
|
|
公司总编辑接受 |
|
2021-06-28 16:24 |
|
预出版 |
|
2021-06-28 16:24 |
|
缴纳版面费 |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
排版 |
|
2021-09-08 01:08 |
|
在线出版 |
|
2021-09-08 11:53 |
ISSN |
1009-3079 (print) and 2219-2859 (online) |
开放获取 |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
版权 |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
网址 |
http://www.wjgnet.com |
专业类型 |
消化肿瘤学 |
手稿栏目类型 |
临床研究 |
文章标题 |
术前CRP/Alb、GGT指标的检测对肝细胞癌切除术后早期复发预测价值
|
手稿来源 |
自由来稿 |
所有作者列表 |
梁寻杰, 黄赞松 |
ORCID |
|
基金项目及其编号 |
基金项目名称 |
基金编号 |
广西自然科学基金资助项目 |
No. 2014GXNSFAA118143 |
广西科技基地与人才专项(广西肝胆疾病临床医学研究中心研究课题) |
No. AD17129025 |
2017年度广西医药卫生自筹经费计划课题 |
No. Z20170224 |
|
通讯作者 |
黄赞松, 研究生, 教授, 主任医师, 533000, 广西壮族自治区百色市中山二路18号, 右江民族医学院附属医院消化内科. 1019846481@qq.com |
关键词 |
肝细胞癌; CRP/Alb; GGT; 复发; 预后 |
核心内容提要 |
C-反应蛋白/血清白蛋白比值(creaction protein to albumin ratio, CRP/Alb)及谷氨酰转肽酶(gamma-glutamyl transferase, GGT)作为新兴的生物标志物被研究发现是肝细胞癌(hepatocellular carcinoma, HCC)治疗的预后危险因素, 这为其在临床实践应用中提供了依据, 对区别一些肝癌复发率高、预后差的患者起到很大作用. |
出版日期 |
2021-09-08 11:53 |
引文著录 |
梁寻杰, 黄赞松. 术前CRP/Alb、GGT指标的检测对肝细胞癌切除术后早期复发预测价值. 世界华人消化杂志 2021; 29(17): 999-1005 |
URL |
https://www.wjgnet.com/1009-3079/full/v29/i17/999.htm |
DOI |
https://dx.doi.org/10.11569/wcjd.v29.i17.999 |
© 2004-2022 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345